|Description||Isocarboxazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) belonging to the hydrazine class. It is primarily used to treat mood and anxiety disorders. It is also used for the treatment of Parkinson's disease and other dementia-related disorders. It is also effective in the treatment of major depression, dysthymic disorder, and atypical depression. It blocks the breakdown (oxidative deamination) of biogenic amines by inhibiting MAO, thereby increasing the concentrations of norepinephrine and 5-hydroxytrytamine at central aminergic receptors. It was developed by Validus and has been listed.|
|Appearance||White to Pale Yellow Solid|
|Synonyms||1-Benzyl-2-(5-methyl-3-isoxazolylcarbonyl)hydrazine;3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide;3-Isoxazolecarboxylic acid, 5-methyl-, 2-benzylhydrazide;5-Methyl-3-isoxazole-carboxylic Acid 2-Benzylhydrazide;3-(N-Benzylhydrazinocarbon|
|Solubility||Acetontrile (Slightly), Chloroform (Slightly), Methanol (Slightly)|
|Application||Isocarboxazid is primarily used to treat mood and anxiety disorders. It is also used for the treatment of Parkinson's disease and other dementia-related disorders. It is also effective in the treatment of major depression, dysthymic disorder, and atypical|
|Quality Standard||In-house standard|
|Quantity||Grams to Kilograms|
|Boiling Point||394.5±42.0 °C | Condition: Press: 760 Torr|
|Melting Point||105-106 °C|
|Density||1.206±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
|Current Developer||Isocarboxazid was developed by Validus and has been listed.|
Isocarboxazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) belonging to the hydrazine class. It is primarily used to treat mood and anxie...
N 0430 hydrobromide
N 0430 hydrobromide is a monoamine oxidase (MAO) inhibitor and a dopamine agonist.
N 0432 hydrobromide
N 0432 hydrobromide is a monoamine oxidase (MAO) inhibitor and a dopamine agonist.
Safinamide, a selective MAO-B inhibitor, could be effective against Parkinson’s disease for patients mid-to-late-stage. IC50: 98 nM.
Indantadol is a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain.
Lazabemide, a pyridine derivative, is a reversible and selective monoamine oxidase B inhibitor that has probable effect for Parkinson's disease. IC50: 30 nM. It...
Ro 41-1049 hydrochloride
The hydrochloride salt form of Ro 41-1049 which is a MAO-A inhibitor and probably could be used in the study of Parkinson's disease.
Rasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug.
Paeonol is a phenolic compound found in peonies, acting as a MAO-A and MAO-B inhibitor (IC50 values of 54.6 μM and 42.5 μM, respectively). Paeonol exhibits anti...
Modaline sulfate, also called as W3207B, is an active inhibitor of monoamine oxidase to treat depression.
Rasagiline, an Indapamide derivative, has been found to be a MAO-B inhibitor that could be used to against Parkinson's disease. IC50: 4.4nM.
Hemisulphate salt form of Mephentermine which could be a cardioexcitatory agent for acting as a α-adrenoceptor agonist and it has already been used against low ...
(-)-N 0425 hydrochloride
(-)-N 0425 hydrochloride is a potent monoamine oxidase (MAO) inhibitor.
Torezolid phosphate is a novel oxazolidinone for gram-positive infections, has an IC50 of 8.7 μM and 5.7 μM for monoamine oxidase (MAO)-A and MAO-B, respectivel...
Pargyline hydrochloride, a benzene derivative, is an irreversible monoamine oxidase (MAO) inhibitor that is used clinically to treat moderate hypertension but i...
Iproniazid phosphate is a non-selective, irreversible inhibitor of monoamine oxidase (MAOI) that has potential to treat hypertension.
Minaprine, also called as Agr 1240 or Cantor, an atypical antidepressant drug which is effective in most animal models of depression, is a reversible inhibitor ...
Nialamide is used as an antidepressant for it is a monoamine oxidase inhibitor (MAOI) of the hydrazine class. It might be efficient under the combination action...
NS-2359, a serotonin-norepinephrine-dopamine reuptake inhibitor, may be able to reduce cocaine withdrawal symptoms, reduce cocaine craving and reduce cocaine-in...
Brofaromine Hydrochloride is a reversible inhibitor of monoamine oxidase A(RIMA). It acts on norepinephrine, epinephrine, serotonin and dopamine. It was mainly ...